EFFICACY AND SAFETY OF ABATACEPT IN PATIENTS WITH RA AND AN INADEQUATE RESPONSE TO ANTI-TNF THERAPY BY NUMBER OF PRIOR ANTI-TNF THERAPIES USED

被引：0
|
作者：
Schiff, M.
Le Bars, M.
Gaillez, C.
Wu, G.
Poncet, C.
Genovese, M. C.
机构：
[1] Univ Colorado, Boulder, CO 80309 USA
[2] Bristol Myers Squibb Co, Princeton, NJ USA
[3] Stanford Univ, Stanford, CA 94305 USA
来源：
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2010年 / 16卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S29 / S30
页数：2
相关论文
共 50 条
  • [1] Time to treatment response with abatacept in patients with RA and an inadequate response to Anti-TNF therapy
    Schiff, M.
    Dougados, M.
    Le Bars, M.
    Lafosse, C.
    Koncz, T.
    Genovese, M. C.
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S307 - S308
  • [2] The efficacy and safety of abatacept in patients with active rheumatoid arthritis and an inadequate response to anti-TNF therapy: Results from the arrive trial
    Emery, P.
    Pritchard, C.
    Zhou, X.
    Genovese, M.
    Schiff, M.
    [J]. RHEUMATOLOGY, 2008, 47 : II45 - II45
  • [3] Safety of anti-TNF therapy in RA patients with Hepatitis C
    Pittman, Cory B.
    Joseph, Amy M.
    Mody, Ami
    Gutierrez, Ernesto
    Ali, Zarmeena
    Richards, John Steuart
    Kerr, Gail S.
    Reimold, Andreas
    Rangan, Bavana V.
    Hooker, Roderick
    McTigue, Joan
    Edwards, Larry
    Robinson, Nichole
    Eisen, Seth
    Fimmel, Claus
    Kanwal, Fasiha
    Ranganathan, Prabha
    [J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (12): : 4279 - 4279
  • [4] Abatacept has beneficial effects in rheumatoid arthritis patients with an inadequate response to anti-TNFα therapy
    Genovese, MC
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (06) : 767 - 768
  • [5] Obesity impairs efficacy of anti-TNF therapy in patients with RA
    Miguel A. González-Gay
    Carlos González-Juanatey
    [J]. Nature Reviews Rheumatology, 2012, 8 : 641 - 642
  • [6] Abatacept and anti-TNF monoclonal antibodies: efficacy and safety comparisons
    Schiff, M.
    Dougados, M.
    Fleischmann, R.
    Fay, J.
    Maldonado, M.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 103 - 103
  • [7] ABATACEPT AND ANTI-TNF MONOCLONAL ANTIBODIES: EFFICACY AND SAFETY COMPARISONS
    Schiff, M.
    Dougados, M.
    Fleischmann, R.
    Fay, J.
    Maldonado, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 461 - 462
  • [8] Efficacy of abatacept following wash-out of anti-TNF therapy in rheumatoid arthritis patients in the ATTAIN (Abatacept Trial in Treatment of Anti-TNF INadequate Responders) trial: Current versus prior discontinuation.
    Genovese, M
    Schiff, M
    Luggen, M
    Aranda, R
    Becker, JC
    White, A
    Dougados, M
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S560 - S561
  • [9] The safety of abatacept in patients with active rheumatoid arthritis and an inadequate response to anti-TNF therapy: Results from the arrive trial
    Schiff, M.
    Pritchard, C.
    Teng, J.
    Bahrt, K.
    Genovese, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 89 - 89
  • [10] Abatacept has beneficial effects in rheumatoid arthritis patients with an inadequate response to anti-TNFα therapy -: Comment
    Emery, P
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2005, 23 (06) : 768 - 768
12345